Marinomed Biotech AG | WebDisclosure

Basculer en Français

11189	Companies
247545	Keywords
175382	Articles
133771	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 07/16/2026 at 23:10, 3 months ago

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
Marinomed Biotech AG to apply for court restructuring proceedings without self-administration due to failed negotiations and insolvency risk. Aim to secure financial stability

Marinomed Biotech AG Financial Stability Insolvency Risk Restructuring Proceedings Court-approved Restructuring Plan
BRIEF

published on 05/19/2026 at 08:03, 4 months 28 days ago

Marinomed Biotech AG Forms Strategic Partnership for Marinosolv® in Inhalation Therapy

Strategic Partnership Biopharmaceuticals Respiratory Medicine Marinosolv® Technology Inhalation Therapy
BRIEF

published on 05/19/2026 at 08:03, 4 months 28 days ago

Marinomed Biotech AG conclut un partenariat stratégique pour Marinosolv® en thérapie par inhalation

Partenariat Stratégique Produits Biopharmaceutiques Pneumologie Technologie Marinosolv® Thérapie Par Inhalation
PRESS RELEASE

published on 05/19/2026 at 07:58, 4 months 28 days ago

Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy
Marinomed Biotech AG partners with Phargentis SA for worldwide licensing of Marinosolv® Technology in Inhalation Therapy, offering advanced drug delivery solutions for respiratory medicine

Marinomed Biotech AG Drug Delivery Marinosolv® Technology Inhalation Therapy Phargentis SA
BRIEF

published on 05/11/2026 at 11:14, 5 months 5 days ago

Marinomed lance son collyre à base de tacrolimus sur le marché des préparations magistrales.

Marinomed Biotech AG Plateforme Marinosolv Collyre De Tacrolimus Marché À Effet Cumulatif Inflammation Oculaire
BRIEF

published on 05/11/2026 at 11:14, 5 months 5 days ago

Marinomed Advances Tacrolimus Eyedrops to Compounding Market

Marinomed Biotech AG Marinosolv Platform Tacrolimus Eyedrops Compounding Market Ocular Inflammation
PRESS RELEASE

published on 05/11/2026 at 11:09, 5 months 5 days ago

Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market, targeting niche patient populations and high-need therapeutic areas with a strategic commercial milestone

Marinomed Biotech AG Marinosolv Technology Tacrolimus Eyedrops Compounding Market Ophthalmologists
BRIEF

published on 04/22/2026 at 09:09, 5 months 24 days ago

Marinomed Biotech AG Expands into Compounding Services

Global Expansion Marinomed Biotech Marinosolv Technology Compounding Services Customized Medicines
BRIEF

published on 04/22/2026 at 09:09, 5 months 24 days ago

Marinomed Biotech AG se développe dans le domaine des services de préparation magistrale

Expansion Mondiale Technologie Marinosolv Biotechnologie Marinomed Services De Préparation Magistrale Médicaments Personnalisés
PRESS RELEASE

published on 04/22/2026 at 09:04, 5 months 24 days ago

Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology
Marinomed Biotech AG announces strategic expansion into compounding services with Marinosolv technology, offering personalized medicines for global demand

Marinomed Biotech AG Strategic Expansion Marinosolv Technology Compounding Services Personalized Medicines

Accesswire

Published on 10/17/2026 at 03:20, 1 hour 59 minutes ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 hours 4 minutes ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 5 hours 44 minutes ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 5 hours 49 minutes ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 6 hours 19 minutes ago

Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE

EQS Group

Published on 10/16/2026 at 20:08, 9 hours 11 minutes ago

EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 9 hours 59 minutes ago

Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 10 hours 14 minutes ago

Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 11 hours 1 minute ago

Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 11 hours 6 minutes ago

EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance

Les Echos

Published on 10/16/2026 at 19:54, 9 hours 25 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 10 hours 31 minutes ago

Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 10 hours 31 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 11 hours 19 minutes ago

KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
Published on 10/16/2026 at 07:30, 21 hours 49 minutes ago

Third Quarter Revenues 2026

View all LES ECHOS COMFI WIRE